The selection of site is one of the important environmental conditions for the production of plutonium. The selection of the site directly relates to the production performance and economic benefits of plutonium. Therefore, it is necessary to pay attention to the selection of the site of the market.
(1) The topographic terrain should be built in a place with sunny leewards, good ventilation, convenient drainage, high dry terrain, low soil compressibility, and low groundwater level. It can't be built in places where the depressions and floods are washed away.
(2) Convenient transportation The market should choose convenient transportation. However, in order to prevent the spread of the disease, the feeding farm should be more than 500 meters away from the main road and 100 meters above the secondary road.
(3) Water and water sufficient for water is essential for life activities. It is an important material for the formation of eggs, meat and carcasses. Therefore, the water source should be sufficient, the water quality should be better, and it should meet the drinking water hygiene standards or livestock drinking water production standards. Electricity must be sufficient, there can be no power outage, and power can also be provided. Stay away from residential areas, other livestock farms and pollution sources. In order to prevent the breeding environment from polluting the surrounding environment and contaminating the breeding grounds with external pathogenic microorganisms, there should be natural isolation belts such as mountains, water, forests, or ravines around the farm, away from industrial pollution areas, away from towns and villages, and away from other poultry farms. It is not less than 1,500 meters from these places. Such a site is conducive to disease prevention and health of the flock, and it can also reduce the environmental pollution to the market.
Ziprasidone Intermediates
Ziprasidone is a medication of the atypical antipsychotic type. It is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in people with schizophrenia. Ziprasidone is also used off-label for depression, bipolar maintenance, and posttraumatic stress disorder.
Ziprazidone is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate.
We produce a series of complete intermediates for Ziprasidone, intermediate I (CAS No. 2634-33-5) and intermediate II (CAS No. 7716-66-7) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Ziprasidone Intermediates,Cas 7716-66-7 ,Cas 2634-33-5,Ziprasidone Hydrochloride Intermediate
Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com